These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 10462266)

  • 1. Endothelin ET(A) receptor blockade prevents the progression of renal failure and hypertension in uraemic rats.
    Brochu E; Lacasse S; Moreau C; Lebel M; Kingma I; Grose JH; Larivière R
    Nephrol Dial Transplant; 1999 Aug; 14(8):1881-8. PubMed ID: 10462266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Supplementation with a low dose of L-arginine reduces blood pressure and endothelin-1 production in hypertensive uraemic rats.
    Dumont Y; D'Amours M; Lebel M; Larivière R
    Nephrol Dial Transplant; 2001 Apr; 16(4):746-54. PubMed ID: 11274268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of endothelin-1 antagonists on erythropoietin-induced hypertension in renal failure.
    Brochu E; Lacasse S; Larivière R; Kingma I; Grose JH; Lebel M
    J Am Soc Nephrol; 1999 Jul; 10(7):1440-6. PubMed ID: 10405199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased immunoreactive endothelin-1 levels in blood vessels and glomeruli of rats with reduced renal mass.
    Larivière R; D'Amours M; Lebel M; Kingma I; Grose JH; Caron L
    Kidney Blood Press Res; 1997; 20(6):372-80. PubMed ID: 9453448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats.
    Dumont Y; D'Amours M; Lebel M; Larivière R
    J Hypertens; 2001 Aug; 19(8):1479-87. PubMed ID: 11518857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of losartan and captopril on endothelin-1 production in blood vessels and glomeruli of rats with reduced renal mass.
    Larivière R; Lebel M; Kingma I; Grose JH; Boucher D
    Am J Hypertens; 1998 Aug; 11(8 Pt 1):989-97. PubMed ID: 9715793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of renal dysfunction in rats with chronic heart failure after myocardial infarction by treatment with the endothelin A receptor antagonist, LU 135252.
    Bauersachs J; Braun C; Fraccarollo D; Widder J; Ertl G; Schilling L; Kirchengast M; Rohmeiss P
    J Hypertens; 2000 Oct; 18(10):1507-14. PubMed ID: 11057440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelin receptor A blockade reduces proteinuria and vascular hypertrophy in spontaneously hypertensive rats on high-salt diet in a blood-pressure-independent manner.
    Trenkner J; Priem F; Bauer C; Neumayer HH; Raschak M; Hocher B
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():385S-388S. PubMed ID: 12193128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma and blood vessel endothelin-1 concentrations in hypertensive uremic rats treated with erythropoietin.
    Lebel M; Lacasse-M S; Larivière R; Kingma I; Grose JH
    Clin Exp Hypertens; 1998 Nov; 20(8):939-51. PubMed ID: 9817611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remodeling of resistance arteries in renal failure: effect of endothelin receptor blockade.
    Amann K; Mil Tenberger-Mil Tenyi G; Simonoviciene A; Koch A; Orth S; Ritz E
    J Am Soc Nephrol; 2001 Oct; 12(10):2040-2050. PubMed ID: 11562402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic nitric oxide inhibition aggravates hypertension in erythropoietin-treated renal failure rats.
    Moreau C; Larivière R; Kingma I; Grose JH; Lebel M
    Clin Exp Hypertens; 2000; 22(7-8):663-74. PubMed ID: 11131043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats.
    Larivière R; Moreau C; Rodrigue ME; Lebel M
    Prostaglandins Leukot Essent Fatty Acids; 2004 Aug; 71(2):103-9. PubMed ID: 15207526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal and vascular effects of chronic nitric oxide synthase inhibition: involvement of endothelin 1 and angiotensin II.
    D'Amours M; Lebel M; Grose JH; Larivière R
    Can J Physiol Pharmacol; 1999 Jan; 77(1):8-16. PubMed ID: 10535660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
    Li JS; Turgeon A; Schiffrin EL
    Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of chronic renal allograft rejection in rats with an oral endothelin A receptor antagonist.
    Braun C; Conzelmann T; Vetter S; Schaub M; Back WE; Yard B; Kirchengast M; Tullius SG; Schnülle P; van der Woude FJ; Rohmeiss P
    Transplantation; 1999 Sep; 68(6):739-46. PubMed ID: 10515373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ET(A) receptor blockade prevents increased tissue endothelin-1, vascular hypertrophy, and endothelial dysfunction in salt-sensitive hypertension.
    Barton M; d'Uscio LV; Shaw S; Meyer P; Moreau P; Lüscher TF
    Hypertension; 1998 Jan; 31(1 Pt 2):499-504. PubMed ID: 9453352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 in chronic renal failure and hypertension.
    Larivière R; Lebel M
    Can J Physiol Pharmacol; 2003 Jun; 81(6):607-21. PubMed ID: 12839272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin 1 type a receptor antagonism prevents vascular dysfunction and hypertension induced by 11beta-hydroxysteroid dehydrogenase inhibition: role of nitric oxide.
    Ruschitzka F; Quaschning T; Noll G; deGottardi A; Rossier MF; Enseleit F; Hürlimann D; Lüscher TF; Shaw SG
    Circulation; 2001 Jun; 103(25):3129-35. PubMed ID: 11425780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic ETA receptor blockade attenuates cardiac hypertrophy independently of blood pressure effects in renovascular hypertensive rats.
    Ehmke H; Faulhaber J; Münter K; Kirchengast M; Wiesner RJ
    Hypertension; 1999 Apr; 33(4):954-60. PubMed ID: 10205230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different roles of two types of endothelin receptors in partial ablation-induced chronic renal failure in rats.
    Shimizu T; Hata S; Kuroda T; Mihara S; Fujimoto M
    Eur J Pharmacol; 1999 Sep; 381(1):39-49. PubMed ID: 10528132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.